Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Tempus AI posts strong 2025 growth driven by diagnostics, oncology, and data expansion.
TEM
$56.77
-$0.48 -0.84%

Tempus AI posts strong 2025 growth driven by diagnostics, oncology, and data expansion.

Market News
03 Apr 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Tempus AI, a diagnostics and data platform, reported strong performance for 2025 fueled by growth in diagnostics, a rebound in oncology services, and the acquisition of Ambry Genetics. The company’s AI model now processes over 450 petabytes of data, enabling expansion into new products. Its Data & Applications segment is rapidly growing, strengthening Tempus AI's competitive advantage through a large healthcare data moat. This positions the company well for continued innovation and market leadership in clinical decision support.

More News (TEM)

Tempus AI's healthcare data segment revenue jumps 40% YoY, targeting $500M+ in 2026.

Tempus AI's healthcare data segment revenue jumps 40% YoY, targeting $500M+ in 2026.

Tempus AI, Inc. reported a 40% year-over-year increase in its healthcare data segment revenue for Q1 2026, reaching $87 million. This growth is driven by a surge in MRD testing volume, which rose 500% YoY due to a partnership with Personalis for a re...

Analyst Insights
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App